ALEGLITAZAR FOR USE IN THE TREATMENT OR PREVENTION OF MAJOR ADVERSE CARDIAC EVENTS Application WO-2020156683-A1 World Intellectual Property Organisation (WIPO) 06 Aug 2020
ALEGLITAZAR FOR THE TREATMENT OF DIABETIC KIDNEY DISEASE Application WO-2017084989-A1 World Intellectual Property Organisation (WIPO) 26 May 2017